E-Scopics
E-Scopics is a French medical device company that builds software-defined ultrasound systems, enabling hepatologists, gastroenterologists, endocrinologists, and primary care physicians to perform non-invasive point-of-care liver assessment via its FDA-cleared Hepatoscope product and OEM ultrasound platform.
- Company typePrivate
- Founded2018
- HeadquartersSaint-cannat, France
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What E-Scopics does
E-Scopics S.A.S., founded in 2018 and headquartered in Aix-en-Provence, France, builds software-defined ultrasound systems that transform consumer PCs, tablets, and smartphones into diagnostic imaging tools through downloadable applications connected to its proprietary low-power digital probes. The probes capture raw per-channel RF data and leverage ultrafast imaging, bypassing the closed hardware processing of traditional point-of-care ultrasound. Its flagship commercial product is Hepatoscope®, an FDA-cleared (June 2026) and CE-marked point-of-care diagnostic ultrasound system for non-invasive assessment of MASLD/MASH, providing quantitative measurements of liver stiffness for fibrosis and image-brightness parameters for steatosis in roughly four minutes and without requiring prior sonography expertise. E-Scopics also operates an OEM & Research Platform licensing its ultrasound stack to academic and MedTech partners, and participates in the POCUSI consortium (€6.7M France 2030 grant) and the MASLD Diagnostic Coalition.
The company monetizes through three revenue streams: direct sales of Hepatoscope systems (hardware plus software) into hepatology, gastroenterology, endocrinology/diabetology, and primary care; OEM and research licensing of its ultrasound platform to research institutions and MedTech companies; and clinical-research services for high-fidelity raw RF data acquisition. It distributes via direct enterprise field sales and a dedicated OEM contact, with no publicly disclosed pricing and quote-based multi-year contracts. Geographic footprint is dual — Aix-en-Provence headquarters and a U.S. subsidiary (E-Scopics Liver, INC) at BioGenerator Labs in St. Louis — serving EMEA and North America. Leadership consists of ultrasound industry veterans Claude Cohen-Bacrie (Founder & CEO) and François Maurice (Co-Founder & CTO), with a core team averaging 20+ years of ultrasound experience.
E-Scopics firmographics
Firmographics- Name
- E-Scopics
- Legal name
- E-Scopics S.A.S.
- Website
- https://e-scopics.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- E-Scopics is a French medical device company that builds software-defined ultrasound systems, enabling hepatologists, gastroenterologists, endocrinologists, and primary care physicians to perform non-invasive point-of-care liver assessment via its FDA-cleared Hepatoscope product and OEM ultrasound platform.
- Ownership category
- akta.pro rank
E-Scopics industry classification
Industry- Product category
- Point-of-Care Ultrasound Diagnostics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Ultrasound & Echography Systems (HLAHABAD)
Keywords
Where E-Scopics is headquartered
LocationHeadquarters
- HQ city
- Saint-cannat
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
E-Scopics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Hepatoscope Product Sales: Commercial sales of the FDA-cleared and CE-marked Hepatoscope point-of-care liver assessment system, including the digital probe hardware and software application for clinical use in hepatology, gastroenterology, endocrinology, and primary care settings.
- OEM Platform Licensing: Licensing of foundational ultrasound technology to research institutions and corporate partners. Provides fully software-based ultrasound platform for clinical research and specialized imaging product development.
- Clinical Research Services: Platform licensing for advanced clinical acquisitions in the field. Ideal for researchers who need high-fidelity data but find traditional systems too bulky or restrictive for clinical trials.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for Hepatoscope and OEM platforms |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
E-Scopics product offering
Product offeringCore offering
E-Scopics develops a 100% software-based ultrasound platform that transforms standard PCs, tablets, and smartphones into high-end diagnostic tools through downloadable software applications connected to smart digital transducers. Its flagship commercial product, Hepatoscope®, is an FDA-cleared and CE-marked point-of-care diagnostic imaging system for non-invasive liver disease assessment (MASLD/MASH), while the OEM & Research Platform licenses the foundational ultrasound technology to research institutions and MedTech partners.
Product overview
E-Scopics offers a unified product ecosystem centered on its software-based ultrasound platform. The flagship product is Hepatoscope®, an FDA-cleared and CE-marked point-of-care liver assessment tool that provides quantitative imaging parameters for MASLD and MASH screening. This product integrates with the Digital Probe (smart digital transducer) and E-Scopics Software App for image reconstruction and analysis. Additionally, the company provides an OEM & Research Platform for B2B licensing of their foundational ultrasound technology to research institutions and MedTech partners.
Differentiator
Problem solved
Functional benefit
Brands
- Hepatoscope®: The first purely software-based, point-of-care liver assessment tool for non-invasive diagnosis of MASLD and MASH. FDA-Cleared & CE-Marked diagnostic ultrasound imaging system.
Products and services
- Hepatoscope® FDA-cleared and CE-marked point-of-care diagnostic ultrasound imaging system designed for non-invasive assessment of liver disease (MASLD/MASH). Provides quantitative imaging parameters including Liver Stiffness measurements for fibrosis assessment and quantitative ultrasound parameters for steatosis quantification. Designed for hepatologists, gastroenterologists, endocrinologists, diabetologists, and primary care physicians with 4-minute assessment capability.
- OEM & Research Platform B2B ultrasound system OEM platform providing fully software-based ultrasound technology licensing for research institutions and corporate MedTech partners. Offers raw per-channel RF data access, clinical research licensing, and OEM manufacturing capabilities for companies needing high-performance ultrasound OEM components to bring specialized imaging products to market faster.
Quantifiable outcome
- 0.93 correlation coefficient with MRI-PDFF reference standard for liver fat quantification
- +3 more outcomes
Companies that use E-Scopics
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles2 records
E-Scopics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
E-Scopics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- MASLD Diagnostic CoalitioncoreMASHNET announced formation of the MASLD Diagnostic Coalition to improve access and awareness of non-invasive diagnostics for MASLD. Founding members include Echosens, E-Scopics, Labcorp, Perspectum, Siemens Healthineers, and Sonic Incytes. The coalition aims to advance early detection, public education, and collaborative efforts to address underdiagnosis and rising prevalence of MASLD and MASH, supported by Novo Nordisk.
- POCUSI Consortium PartnerscorePOCUSI is a French research consortium awarded €6.7 million under France 2030 plan to develop next-generation software-based, smart, and frugal ultrasound imaging devices. E-Scopics leads this multidisciplinary initiative with partners including Bpifrance, INRIA, and IHU Strasbourg. The project aims to enhance medical ultrasound accessibility, especially for chronic liver diseases, and establish technological sovereignty in medical imaging.
- IHU StrasbourgminorIHU Strasbourg (Institut Hospitalo-Universitaire) collaborating as partner in the POCUSI consortium for medical imaging research and development.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
E-Scopics competitors and assessment
Company assessmentDirect peers
- Butterfly Network: Butterfly Network builds software-based, smartphone-connected point-of-care ultrasound systems (iQ/iQ3) — the closest analog to E-Scopics' software-centric ultrasound architecture and probe-to-consumer-device model, both targeting democratization of premium ultrasound at the point of care.
- Echosens: Echosens' FibroScan is the dominant non-invasive liver stiffness measurement platform in hepatology — directly overlapping Hepatoscope's clinical decision point in chronic liver disease assessment, and a fellow founding member of the MASLD Diagnostic Coalition.
- Clarius Mobile Health: Clarius produces wireless, app-based handheld ultrasound scanners that pair with smartphones and tablets — a directly comparable software-driven, ultra-portable ultrasound architecture targeting similar POC clinical use cases as E-Scopics.
- Sonic Incytes: Sonic Incytes develops Velacur, a quantitative ultrasound-based liver assessment tool for steatosis and stiffness — directly competing with Hepatoscope on the same MASLD/MASH clinical workflow and a fellow MASLD Diagnostic Coalition founding member.
Broad incumbents
- Siemens Healthineers: A leading global ultrasound and imaging incumbent with ACUSON POC systems and broader imaging portfolio. Coalition co-member in the MASLD Diagnostic Coalition and a credible enterprise channel for hepatology and gastroenterology deployments where E-Scopics also competes.
- Philips: Philips' Lumify is a smartphone-connected POC ultrasound system — architecturally similar to E-Scopics' consumer-device-based ultrasound approach — and Philips' broader ultrasound installed base gives it a credible incumbency threat across hepatology and primary care.
- GE HealthCare: GE HealthCare's Vscan Air and LOGIQ POC ultrasound lines compete with E-Scopics on portable, software-driven ultrasound, while the parent portfolio spans imaging, ultrasound, and diagnostics that overlap Hepatoscope's hepatology and primary-care positioning.
- Samsung Medison: Samsung Medison is a global ultrasound and women's health imaging player with POC and portable systems that compete in the same enterprise hepatology and primary-care channels E-Scopics targets.
- Fujifilm Sonosite: Fujifilm's Sonosite division is a long-standing POC ultrasound leader with a strong point-of-care installed base across emergency medicine, anesthesia, and increasingly hepatology — directly competing with Hepatoscope for POC procedure workflows.
Emerging players
- Perspectum: Perspectum's LiverMultiScan provides MRI-based quantitative liver assessment — addressing the same MASLD/MASH diagnostic decision point via a complementary (imaging) modality and a fellow MASLD Diagnostic Coalition member, anchoring the diagnostic ecosystem E-Scopics participates in.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
E-Scopics social profiles
Digital presenceE-Scopics compliance and trust
Trust signalCompliance2 records
E-Scopics financial estimates
Financial estimateRevenue estimate
Valuation estimate
E-Scopics leadership team
Management profileNumber of profiles
Profiles2 records
E-Scopics subsidiaries and ownership
Company hierarchySubsidiaries1 record
E-Scopics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
E-Scopics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about E-Scopics
What does E-Scopics do?
E-Scopics develops a 100% software-based ultrasound platform that transforms standard PCs, tablets, and smartphones into high-end diagnostic tools through downloadable software applications connected to smart digital transducers. Its flagship commercial product, Hepatoscope®, is an FDA-cleared and CE-marked point-of-care diagnostic imaging system for non-invasive liver disease assessment (MASLD/MASH), while the OEM & Research Platform licenses the foundational ultrasound technology to research institutions and MedTech partners.
Is E-Scopics a public or private company?
E-Scopics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was E-Scopics founded?
E-Scopics was founded in 2018. It employs 1 to 10 people.
Where is E-Scopics based?
E-Scopics is headquartered in Saint-cannat, France, in the Europe region.
How does E-Scopics make money?
Three revenue lines are on record. Hepatoscope Product Sales are the primary driver. The others are OEM Platform Licensing and clinical Research Services.
Who are E-Scopics's main competitors?
Direct peers on record are Butterfly Network, Echosens, Clarius Mobile Health and Sonic Incytes. Broad incumbents are Siemens Healthineers, Philips, GE HealthCare, Samsung Medison and Fujifilm Sonosite. Perspectum is listed as an emerging player.
Does E-Scopics have an API?
No public API is recorded for E-Scopics.
What industry is E-Scopics in?
E-Scopics's product category is Point-of-Care Ultrasound Diagnostics. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems. Its NAICS code is 334510 and its SIC code is 3841.